Compare FC & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FC | APYX |
|---|---|---|
| Founded | 1983 | 1982 |
| Country | United States | United States |
| Employees | N/A | 220 |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.5M | 128.0M |
| IPO Year | 1994 | 1995 |
| Metric | FC | APYX |
|---|---|---|
| Price | $12.20 | $3.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $26.00 | $7.00 |
| AVG Volume (30 Days) | ★ 119.1K | 58.8K |
| Earning Date | 04-10-2026 | 04-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 19.40 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $267,067,000.00 | N/A |
| Revenue This Year | $3.02 | $9.36 |
| Revenue Next Year | $3.66 | $6.70 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.17 | $0.83 |
| 52 Week High | $31.48 | $4.50 |
| Indicator | FC | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 15.73 | 44.44 |
| Support Level | N/A | $3.30 |
| Resistance Level | $20.33 | $4.40 |
| Average True Range (ATR) | 0.85 | 0.20 |
| MACD | -0.21 | -0.03 |
| Stochastic Oscillator | 7.90 | 30.61 |
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.